Director dealings: Poolbeg Pharma co-founder ups stake

19th Feb 2024 14:22

(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.

Friel, who co-founded Poolbeg Pharma, purchased the shares at an average price of 11.68p each, for a total value of £96,944.

Following the transaction, Friel holds 37.21m ordinary Poolbeg shares, representing approximately 7.4% of the company's issued share capital.

As of 1620 GMT, Poolbeg shares were up 0.88% at 11.50p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Poolbeg Pharma (POLB)

Director name: Friel,Cathal

Amount purchased: 830,000 @ 11.68p

Value: £96,944.00

Oryx International Growth Fund Ltd. (OIG)

Director name: Mills,Christopher

Amount purchased: 6,500 @ 1,147.30p

Value: £74,574.50

Oryx International Growth Fund Ltd. (OIG)

Director name: Mills,Christopher

Amount purchased: 4,500 @ 1,150.00p

Value: £51,750.00

Alphawave Ip Group (AWE)

Director name: Fonseca,Michelle Senecal de

Amount purchased: 25,284 @ 153.40p

Value: £38,785.66

(HWG)

Director name: Patmore,Katerina

Amount purchased: 114 @ 131.89p

Value: £150.35

(HWG)

Director name: Shillaw,Lynda

Amount purchased: 114 @ 131.89p

Value: £150.35

(HWG)

Director name: Birch,Chris

Amount purchased: 114 @ 131.89p

Value: £150.35

Xp Factory (XPF)

Director name: Harpham,Richard

Amount purchased: 939 @ 15.89p

Value: £149.21

Xp Factory (XPF)

Director name: Bird,Graham

Amount purchased: 939 @ 15.89p

Value: £149.21

Tesco (TSCO)

Director name: Murphy,Ken

Amount purchased: 49 @ 276.84p

Value: £135.65

Top Director Sells